Ovarian Cancer

The Pharmacy Times® Ovarian Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to the group of diseases that originates in the ovaries, fallopian tubes, or the peritoneum.

Latest News

NCCN Flash Update: Ovarian Cancer Guidelines Version 3.2025 Released With Maintenance Therapy Adjustment for HR-Deficiency
NCCN Flash Update: Ovarian Cancer Guidelines Version 3.2025 Released With Maintenance Therapy Adjustment for HR-Deficiency

July 18th 2025

The National Comprehensive Cancer Network (NCCN) has updated its ovarian cancer guidelines version 3.2025 to recommend niraparib as maintenance therapy for patients with BRCA wild-type or homologous recombination (HR)–deficiency who did not receive bevacizumab during primary treatment.

Teal ribbon for ovarian cancer awareness -- Image credit: Queenmoonlite Studio | stock.adobe.com
FDA Approves Avutometinib/Defactinib for Adults With KRAS-Mutated Recurrent LGSOC

May 8th 2025

Ovarian cancer -- Image credit: Dr_Microbe | stock.adobe.com
INX-315 Granted FDA Fast Track Designation for Platinum-Resistant/Refractory Ovarian Cancer

May 5th 2025

Ovarian cancer -- Image credit: Lars Neumann | stock.adobe.com
CUSP06 Granted FDA Fast Track Designation for Patients With Platinum-Resistant Ovarian Cancer

February 13th 2025

Ovarian cancer, 3D illustration - Image credit: Dr_Microbe | stock.adobe.com
Avutometinib Plus Defactinib Moves One Step Closer to Approval for Treatment of Ovarian Cancer

January 6th 2025

Video Series
Video Interviews
Podcasts

More News